1.Community-Acquired Pneumococcal Pneumonia in Highly Vaccinated Population: Analysis by Serotypes, Vaccination Status, and Underlying Medical Conditions
Hakjun HYUN ; A-Yeung JANG ; Jin Woong SUH ; In-Gyu BAE ; Won Suk CHOI ; Yu Bin SEO ; Jacob LEE ; Jin Gu YOON ; Ji Yun NOH ; Hee Jin CHEONG ; Woo Joo KIM ; Min Ja KIM ; Joon Young SONG
Journal of Korean Medical Science 2023;38(42):e330-
Background:
Targeted risk population has been highly vaccinated against pneumococcal diseases in South Korea. Despite this, the pneumococcal serotype distribution is evolving, which impedes efficient roll-out of vaccines.
Methods:
This prospective cohort study included patients aged ≥ 19 years with communityacquired pneumonia (CAP) from five university hospitals in South Korea between September 2018 and July 2021. The outcomes of interest were the demographic and clinical characteristics of patients with CAP, pneumococcal serotype distribution, and risk factors of 30-day mortality in patients with pneumococcal CAP (pCAP). Considering the high seroprevalence, we analyzed the clinical characteristics of serotype 3 pCAP.
Results:
A total of 5,009 patients hospitalized with CAP was included (mean age ± standard deviation, 70.3 ± 16.0 years; 3,159 [63.1%] men). Streptococcus pneumoniae was the leading causative agent of CAP (11.8% overall, 17.7% in individuals aged < 65 years with chronic medical conditions). Among the 280 serotyped Streptococcus pneumococcus, serotype 3 was the most common (10.0%), followed by serotypes 19A (8.9%), 34 (8.9%), and 35B (8.9%).Non-vaccine serotypes (serotype 35B [13.9%] and 34 [12.0%]) were the most prevalent in 108 individuals vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23).Serotype 3 was prevalent, irrespective of PPSV23 vaccination status, and more common in individuals with chronic lung disease (P = 0.008). Advanced age (adjusted odds ratio [aOR], 1.040; 95% confidence interval [CI], 1.011–1.071), long-term care facility residence (aOR, 2.161; 95% CI, 1.071–4.357), and bacteremia (aOR, 4.193; 95% CI, 1.604–10.962) were independent risk factors for 30-day mortality in patients with pCAP. PPSV23 vaccination reduced the risk of mortality (aOR, 0.507; 95% CI, 0.267–0.961).
Conclusion
Serotype 3 and 19A were still the most common serotypes of pCAP in South Korea despite the national immunization program of 13-valent pneumococcal conjugated vaccine in children and PPSV23 in old adults. PPSV23 vaccination might reduce the risk of mortality in patients with pCAP.
2.The Antibiotic Cement Coated Nail and Masquelet Technique for the Treatment of Infected Nonunion of Tibia with Bone Defect and Varus Deformity
Min Gu JANG ; Jae Hwang SONG ; Dae Yeung KIM ; Woo Jin SHIN
Journal of the Korean Fracture Society 2022;35(1):26-30
Infective nonunion after fracture surgery can cause persistent pain and inflammatory exudate in patients, requiring long-term treatment. To treat infective nonunion, radical debridement of infective bone and soft tissue should be performed, followed by stable internal fixation and bone graft. Multiple treatment strategies need to be considered according to the classification of chronic osteomyelitis, size of the bone defect, degree of bone malalignment, and severity of the soft tissue injury. This paper reports a case of a patient treated with an antibiotic cement-coated nail and a Masquelet technique to treat the infected nonunion of the tibia with a bone defect and varus deformity.
3.Updated recommendations for the treatment of venous thromboembolism
Junshik HONG ; Seo-Yeon AHN ; Yoo Jin LEE ; Ji Hyun LEE ; Jung Woo HAN ; Kyoung Ha KIM ; Ho-Young YHIM ; Seung-Hyun NAM ; Hee-Jin KIM ; Jaewoo SONG ; Sung-Hyun KIM ; Soo-Mee BANG ; Jin Seok KIM ; Yeung-Chul MUN ; Sung Hwa BAE ; Hyun Kyung KIM ; Seongsoo JANG ; Rojin PARK ; Hyoung Soo CHOI ; Inho KIM ; Doyeun OH ; On behalf of the Korean Society of Hematology Thrombosis and Hemostasis Working Party
Blood Research 2021;56(1):6-16
Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is a condition characterized by abnormal blood clot formation in the pulmonary arteries and the deep venous vasculature. It is often serious and sometimes even fatal if not promptly and appropriately treated. Moreover, the later consequences of VTE may result in reduced quality of life. The treatment of VTE depends on various factors, including the type, cause, and patient comorbidities. Furthermore, bleeding may occur as a side effect of VTE treatment. Thus, it is necessary to carefully weigh the benefits versus the risks of VTE treatment and to actively monitor patients undergoing treatment. Asian populations are known to have lower VTE incidences than Western populations, but recent studies have shown an increase in the incidence of VTE in Asia. A variety of treatment options are currently available owing to the introduction of direct oral anticoagulants.The current VTE treatment recommendation is based on evidence from previous studies, but it should be applied with careful consideration of the racial, genetic, and social characteristics in the Korean population.
4.Intramuscular Giant Lipoma of the Anterior Compartment of the Ankle: A Case Report
Min Gu JANG ; Jae Hwang SONG ; Jin Woong YI ; Dae Yeung KIM
Journal of Korean Foot and Ankle Society 2020;24(3):124-127
Intramuscular lipomas are benign adipose tumors of the soft tissues that may resemble liposarcomas because of their size, deep location, and occasionally infiltrative growth. An awareness of their existence is fundamental to treating them correctly, and their differential diagnosis from liposarcoma is essential. Magnetic resonance imaging (MRI) is a useful diagnostic tool to differentiate benign adipose tumors from liposarcoma. Marginal excision and biopsy are required for the definite diagnosis and the treatment of symptomatic intramuscular lipomas. To the best of the authors’ knowledge, this is the first report in South Korea regarding the treatment of an intramuscular giant lipoma of the ankle.
5.Comparative Evaluation of Hormones and Hormone-Like Molecule in Lineage Specification of Human Induced Pluripotent Stem Cells
Seon A CHOI ; Ju Hyun AN ; Seung Hwan LEE ; Geun Hui LEE ; Hae Jun YANG ; Pil Soo JEONG ; Jae Jin CHA ; Sanghoon LEE ; Young Ho PARK ; Bong Seok SONG ; Bo Woong SIM ; Young Hyun KIM ; Ji Su KIM ; Yeung Bae JIN ; Jae Won HUH ; Sang Rae LEE ; Jong Hee LEE ; Sun Uk KIM
International Journal of Stem Cells 2019;12(2):240-250
BACKGROUND AND OBJECTIVES: Proficient differentiation of human pluripotent stem cells (hPSCs) into specific lineages is required for applications in regenerative medicine. A growing amount of evidences had implicated hormones and hormone-like molecules as critical regulators of proliferation and lineage specification during in vivo development. Therefore, a deeper understanding of the hormones and hormone-like molecules involved in cell fate decisions is critical for efficient and controlled differentiation of hPSCs into specific lineages. Thus, we functionally and quantitatively compared the effects of diverse hormones (estradiol 17-β (E2), progesterone (P4), and dexamethasone (DM)) and a hormone-like molecule (retinoic acid (RA)) on the regulation of hematopoietic and neural lineage specification. METHODS AND RESULTS: We used 10 nM E2, 3 μM P4, 10 nM DM, and 10 nM RA based on their functional in vivo developmental potential. The sex hormone E2 enhanced functional activity of hematopoietic progenitors compared to P4 and DM, whereas RA impaired hematopoietic differentiation. In addition, E2 increased CD34⁺CD45⁺ cells with progenitor functions, even in the CD43⁻ population, a well-known hemogenic marker. RA exhibited lineage-biased potential, preferentially committing hPSCs toward the neural lineage while restricting the hematopoietic fate decision. CONCLUSIONS: Our findings reveal unique cell fate potentials of E2 and RA treatment and provide valuable differentiation information that is essential for hPSC applications.
Dexamethasone
;
Humans
;
Induced Pluripotent Stem Cells
;
Pluripotent Stem Cells
;
Progesterone
;
Regenerative Medicine
;
Tretinoin
6.Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.
Junshik HONG ; Seok Jin KIM ; Jae Sook AHN ; Moo Kon SONG ; Yu Ri KIM ; Ho Sup LEE ; Ho Young YHIM ; Dok Hyun YOON ; Min Kyoung KIM ; Sung Yong OH ; Yong PARK ; Yeung Chul MUN ; Young Rok DO ; Hun Mo RYOO ; Je Jung LEE ; Jae Hoon LEE ; Won Seog KIM ; Cheolwon SUH
Cancer Research and Treatment 2015;47(2):173-181
PURPOSE: This study was conducted to evaluate outcomes in adult patients with Burkitt lymphoma (BL) or Burkitt-like lymphoma treated with an rituximab plus hyper-CVAD (R-hyper-CVAD) regimen by focusing on tolerability and actual delivered relative dose intensity (RDI). MATERIALS AND METHODS: Patients > or = 20 years of age and pathologically diagnosed with BL or Burkitt-like lymphoma were treated with at least one cycle of R-hyper-CVAD as the first-line treatment in this study. Eligible patients' case report forms were requested from their physicians to obtain clinical and laboratory data for this retrospective study. RESULTS: Forty-three patients (median age, 51 years) from 14 medical centers in Korea were analyzed, none of which were infected with human immunodeficiency virus. The majority of patients had advanced diseases, and 24 patients achieved a complete response (75.0%). After a median follow-up period of 20.0 months, 2-year event-free and overall survival rates were 70.9% and 81.4%, respectively. Eleven patients (25.6%) were unable to complete the R-hyper-CVAD regimen, including six patients due to early death. The RDIs of adriamycin, vincristine, methotrexate, and cytarabine were between 60% and 65%, which means less than 25% of patients received greater than 80% of the planned dose of each drug. Poor performance status was related to the lower RDIs of doxorubicin and methotrexate. CONCLUSION: R-hyper-CVAD showed excellent treatment outcomes in patients who were suitable for dose-intense chemotherapy. However, management of patients who are intolerant to a dose-intense regimen remains problematic due to the frequent occurrence of treatmentrelated complications.
Adult
;
Burkitt Lymphoma
;
Cytarabine
;
Doxorubicin
;
Drug Therapy
;
Follow-Up Studies
;
HIV
;
Humans
;
Korea
;
Lymphoma*
;
Methotrexate
;
Retrospective Studies
;
Survival Rate
;
Vincristine
7.Comparison of oxidative stress markers in umbilical cord blood after vaginal and cesarean delivery.
Eun Ji NOH ; Yoon Ha KIM ; Moon Kyoung CHO ; Jong Woon KIM ; Jin Wook KIM ; Yeung Ja BYUN ; Tae Bok SONG
Obstetrics & Gynecology Science 2014;57(2):109-114
OBJECTIVE: The purpose of our study was to investigate the effect of the mode of delivery on the oxidant and antioxidant system in umbilical cord blood. METHODS: We performed gas analysis of umbilical venous blood and umbilical arterial blood immediately after delivery in 38 women; eighteen women had a vaginal delivery while 20 women delivered via cesarean section at over 37 weeks gestation. We examined lipid peroxide concentration by thiobarbituric acid reaction, protein carbonyl content by 2,4-dinitrophenylhydrazine reaction, and total antioxidant capacity by oxygen radical absorbance capacity assay. RESULTS: Lipid peroxide levels in umbilical venous blood were significantly higher in patients delivering by planned cesarean section (1.81 +/- 0.06 nmol/mg protein) than those with vaginal delivery (1.24 +/- 0.05 nmol/mg protein) (P < 0.05). Antioxidant capacity in umbilical venous blood was significantly higher in patients delivering by planned cesarean section (119.70 +/- 0.13 microM/microL) than those with a vaginal delivery (118.70 +/- 0.29 microM/microL) (P < 0.05). There was no significant difference in the carbonyl content of umbilical venous blood or in the lipid peroxide, carbonyl content, and total antioxidant capacity of umbilical arterial blood. CONCLUSION: Lipid peroxidation levels and antioxidant capacity in umbilical venous blood were higher in patients delivering by planned cesarean section than those with a vaginal delivery. Therefore, we propose that both the mother and neonate are exposed to higher oxidative stress during cesarean section delivery.
Cesarean Section
;
Female
;
Fetal Blood*
;
Humans
;
Infant, Newborn
;
Lipid Peroxidation
;
Mothers
;
Oxidative Stress*
;
Oxygen
;
Pregnancy
;
Umbilical Cord*
8.Superficial Peroneal Nerve Entrapment Syndrome (A Case Report).
Soo Uk CHAE ; Yeung Jin KIM ; Byong San CHOI ; Ha Heon SONG
Journal of Korean Foot and Ankle Society 2012;16(1):62-64
Superficial peroneal nerve entrapment is an uncommon compression neuropathy, and is frequently associated with a fascial defect and a muscle hernia. The standard treatment of that was the nerve decompression by complete or limited fasciotomy. But, we experienced a case of superficial peroneal nerve entrapment had satisfactory surgical outcome by fascial repair of peroneus muscle.
Decompression
;
Hernia
;
Muscles
;
Peroneal Nerve
9.Two Stage Procedure with a Temporary Antibiotic-impregnated Cement Spacer of Infected Hallux Interphalangeal Joint (A Case Report).
Soo Uk CHAE ; Yeung Jin KIM ; Ha Heon SONG ; Jong Yun KIM
Journal of Korean Foot and Ankle Society 2012;16(2):135-139
The interphalangeal joint (IPJ) of the hallux has received little attention compared with the first metatarsophalangeal joint. But, the hallucal IPJ has several disorders such intra-articular fractures, dorsal dislocation, alignment disorder, and inflammatory or degenerative arthritis. Among these disorders septic arthritis of the IPJ of the hallux is rare. We report a case of sepsis of the hallucal IPJ and adjacent underlying osteomyelitis without neuropathic problem and was performed through infected soft tissue and osseous debridement, temporary antibiotic-impregnated cement spacer, and delayed intercalary allogenic fibular bone graft with K-wire fixation.
Arthritis, Infectious
;
Debridement
;
Dislocations
;
Hallux
;
Intra-Articular Fractures
;
Joints
;
Metatarsophalangeal Joint
;
Osteoarthritis
;
Osteomyelitis
;
Sepsis
;
Transplants
10.Cancer of Unknown Primary Finally Revealed to Be a Metastatic Prostate Cancer: A Case Report.
Jung Yeon CHO ; Eun Jin SHIM ; In Seon KIM ; Eun Mi NAM ; Moon Young CHOI ; Kyung Eun LEE ; Yeung Chul MUN ; Chu Myoung SEOUNG ; Soon Nam LEE ; Dong Eun SONG ; Woon Sup HAN
Cancer Research and Treatment 2009;41(1):45-49
The vast majority of patients with metastatic prostate cancer present with bone metastases and high prostate specific antigen (PSA) level. Rarely, prostate cancer can develop in patients with normal PSA level. Here, we report a patient who presented with a periureteral tumor of unknown primary site that was confirmed as prostate adenocarcinoma after three years with using specific immunohistochemical examination. A 64-year old man was admitted to our hospital with left flank pain associated with masses on the left pelvic cavity with left hydronephrosis. All tumor markers including CEA, CA19-9, and PSA were within the normal range. After an exploratory mass excision and left nephrectomy, the pelvic mass was diagnosed as poorly differentiated carcinoma without specific positive immunohistochemical markers. At that time, we treated him as having a cancer of unknown primary site. After approximately three years later, he revisited the hospital with a complaint of right shoulder pain. A right scapular mass was newly detected with a high serum PSA level (101.7 ng/ml). Tissues from the scapular mass and prostate revealed prostate cancer with positive immunoreactivity for P504S, a new prostate cancer-specific gene. The histological findings were the same as the previous pelvic mass; however, positive staining for PSA was observed only in the prostate mass. This case demonstrates a patient with prostate cancer and negative serological test and tissue staining that turned out to be positive during progression. We suggest the usefulness of newly developed immunohistochemical markers such as P504S to determine the specific primary site of metastatic poorly differentiated adenocarcinoma in men.
Adenocarcinoma
;
Flank Pain
;
Humans
;
Hydronephrosis
;
Male
;
Neoplasm Metastasis
;
Nephrectomy
;
Prostate
;
Prostate-Specific Antigen
;
Prostatic Neoplasms
;
Reference Values
;
Serologic Tests
;
Shoulder Pain
;
Biomarkers, Tumor

Result Analysis
Print
Save
E-mail